As UNC patient Edward Wilkinson approached five years free of cancer, he noticed that the UNC clinic that treated his bladder cancer didn’t have a bell to ring. He was determined to change that.
https://t.co/QJb3S6Lvkr
Robert Svatek, MD of @cgoncology@UTSA joins Rick Bangs to discuss how clinical trials, emerging immunotherapies and patient participation are changing bladder cancer care, and why experts are optimistic about what comes next.
Addressing unmet needs in bladder cancer takes a collective effort. This #PatientAdvocacyDay, we thank @BladderCancerUS for its partnership in helping provide patients with the education, resources, and support they need to advocate for their care. Learn more: https://t.co/GKo4sECSM7
This post is intended for healthcare professionals in the U.S. only.
BCAN unveils patient-centered survey on emotional and financial impacts of #BladderCancer. Meri-Margaret Deoudes, CFRE @BladderCancerUS joins @UroDocAsh@UTMDAnderson to discuss BCAN's New Faces report surveying 1,100 bladder cancer patients across 49 US states. The holistic assessment examined the patient journey from diagnosis through survivorship beyond traditional survival metrics. #WatchNow on UroToday > https://t.co/26DGsYHzYL
BCAN's Bladder Cancer Basics Patient Handbook covers diagnosis, stages, treatment, questions to ask and trusted support resources. Clinicians and advocates can download and share it with patients.
It was 25 years ago when Tony Stefani, a San Francisco Fire Rescue Squad Captain, received news that changed his life forever. Doctors had detected a rare form of cancer, starting in his pelvis. At 49 years old, his entire kidney would need to be removed.
Friday, he stood at San Francisco Fire Station 1, now recovered and in his seventies, on a street renamed in his honor.
STORY: https://t.co/fuLjWZYOGy
BCAN offers patient handbooks, fact sheets, short videos, survivorship care plans, webinars and support resources that clinicians and advocates can share with patients.
#sponsored If you or someone you love was recently diagnosed with cancer—especially bladder cancer—stop scrolling for just a minute. I’ve teamed up with Johnson & Johnson to share 3 things I wish I knew on day one: Not all cancers are the same.
Free @RedMedEd CE opportunity! How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?
Learn from experts @ERPlimackMD@siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
Looking for reliable #BladderCancer information? Check out this podcast episode by @BladderCancerUS highlighting key free resources offered by the Bladder Cancer Advocacy Network to support individuals and families at every stage of their health journeys: https://t.co/iStG7n1vyP